# Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors

> **NCT00254267** · PHASE2 · COMPLETED · sponsor: **Amgen** · enrollment: 35 (actual)

## Conditions studied

- Advanced Gastrointestinal Stromal Tumor

## Interventions

- **DRUG:** AMG 706

## Key facts

- **NCT ID:** NCT00254267
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2007-02
- **Final completion:** 2012-12
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2014-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00254267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00254267, "Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00254267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*